arrow
S

Suyash Mohan

University of Pennsylvania
H指数:39
被引数:7,443

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution Series

复发胶质母细胞瘤的分割式质子再放疗:来自大型单机构系列的临床和剂量学结果

2026-07-020
OAAI
Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot study

基于个性化机器学习指导的 Newly Diagnosed Glioblastoma 患者放射剂量递增:前瞻性试点研究

2026-05-130
OAAI
Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study

WHO定义的IDH野生型胶质母细胞瘤接受放疗后的临床、分子和免疫学生存决定因素:一项大型真实世界队列研究

2026-04-250
OAAI
A phase 2 study of niraparib concomitant with Tumor Treating Fields in patients with recurrent grade 4 glioma

尼拉帕利与肿瘤治疗电场联合治疗复发性4级胶质瘤的2期研究

2026-04-200
OA
Unveiling glioblastoma heterogeneity with deep learning derived MRI subtyping: insights from the global ReSPOND consortium

利用深度学习衍生MRI亚型对胶质母细胞瘤异质性进行解析:全球ReSPOND联盟的见解

2025-11-010
OAAI
Outcomes of SRS and Ipilimumab/Nivolumab Among Patients with Melanoma Brain Metastases

黑色素瘤脑转移患者中SRS和Ipilimumab/Nivolumab的治疗效果

2025-11-010
OAAI
Self-supervised multimodal learning for survival prediction in glioblastoma: a multicenter study from the ReSPOND consortium

用于胶质母细胞瘤生存预测的自监督多模态学习:来自ReSPOND联盟的多中心研究

2025-11-010
PRE
Intratumoral preservation of the stem-like malignant cell proportion in glioblastoma, prognostic impact, and its radiomethylomic signatures

胶质母细胞瘤中类干细胞恶性细胞比例的瘤内保存、预后影响及其放射甲基组学特征

2025-09-010
PRE
Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge

通过联合肿瘤分割 (FeTS) 挑战实现医疗AI算法的公平分散基准测试

2025-07-080
OAAI
The radiogenomic and spatiogenomic landscapes of glioblastoma and their relationship to oncogenic drivers
2025-03-010
OA
AI-GUIDED PERSONALIZED PRECISION RADIATION THERAPY WITH TARGETED DOSE ESCALATION FOR NEWLY DIAGNOSED GLIOBLASTOMA: A MATCHED-CONTROL STUDY
2024-11-110
PRE
SUBTYPING GLIOBLASTOMA FROM JOINT CLUSTERING OF IMAGING AND GENOMIC DATA
2024-11-110
PRE
MULTI-INSTITUTIONAL VALIDATION OF AN AI-BASED MODEL FOR PREDICTION OF TUMOR INFILTRATION AND FUTURE RECURRENCE IN PATIENTS WITH GLIOBLASTOMA: RESULTS FROM THE RESPOND CONSORTIUM
2024-11-110
PRE